Brendel Financial Advisors’s Zura Bio ZURA Stock Holding History

Brendel Financial Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-28,052	Closed	-$167K	–	115
2026 Q1	$167K	Buy	+28,052	New	+$169K	0.08%	94

Other funds holding ZURA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Brendel Financial Advisors's ZURA Position: Q2 2026 in Review

Brendel Financial Advisors sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 28,052 shares — an estimated $167K sold.

Brendel Financial Advisors first reported a position in ZURA in Q1 2026 and held it in 1 quarter. The position peaked at $167K in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

Brendel Financial Advisors reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
Brendel Financial Advisors sold 28,052 Zura Bio shares in Q2 2026, an estimated $167K.
Brendel Financial Advisors first reported a position in Zura Bio in Q1 2026 and held it in 1 quarter.
Brendel Financial Advisors's Zura Bio position peaked at $167K in Q1 2026.
95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Brendel Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.